Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 49

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 49
---
, the maximum number of shares reserved for issuance under the 2021 Plan is increased by a number equal to the lesser of (i) 5% of the shares of common stock issued and outstanding on the last day of the immediately preceding fiscal year and (ii) such smaller number of shares of common stock as determined by the Board. The 2021 ESPP provides that the number of shares reserved and available for issuance will automatically increase each January 1, beginning on January 1, 2022, by the lesser (a) 1,128,42 shares of common stock, (b) 1% of the shares of common stock outstanding on the final day of the immediately preceding calendar year, and (c) such smaller number of shares as determined by the Board. The Board determined not to increase the shares on January 1, 2025 for the 2021 ESPP. The number in the table does not include the increase for the 2021 Plan from January 1, 2025. (3) Does not include purchase rights accruing under the 2021 ESPP as of December 31, 2023, because the purchase rights (and, therefore, the number of shares to be purchased) will not be determined until the end of the purchase period on June 30, 2025. Subject to the number of shares remaining in the share reserve, the maximum number of shares purchasable by any participant in the 2021 ESPP during the purchase period beginning January 1, 2025 and ending on June 30, 2025 is 5,000. (4) Includes shares available for future issues under the 2021 ESPP and 2021 Plan. As of December 31, 2024, 845,312 shares of common stock were available for issuance under the 2021 ESPP and 3,691,145 shares of common stock were available for issuance under the 2021 Plan.

Notice of Annual Meeting of Stockholders and 2025 Proxy Statement | 31

TABLE OF CONTENTS

| ​ | SECURITY OWNERSHIP OF CERTAIN BENEFICIALOWNERS AND MANAGEMENT | ​ |

The following table sets forth certain information regarding the beneficial ownership of common stock as of April 15, 2025, except to the extent otherwise indicated in the footnotes below, by (a) each person known by us to be the beneficial owner of more than 5% of the outstanding shares of common stock, (b)